DELTA

EcoFlow Triples Sales for the 2nd Consecutive Year in 2021

Retrieved on: 
Friday, December 31, 2021

EcoFlow has more than tripled its sales for the second consecutive year, outrunning the global portable power station market's CAGR of 42% .

Key Points: 
  • EcoFlow has more than tripled its sales for the second consecutive year, outrunning the global portable power station market's CAGR of 42% .
  • "The impressive sales growth can be attributed to a few things," said Allen Zheng, Sales Director at EcoFlow.
  • In addition to the rapid sales growth, 2021 has been a milestone year for EcoFlow.
  • EcoFlow also took a more active role in environmental issues and emergency preparedness in 2021.

Tauriga Sciences Inc. Receives Product Endorsement From the State of Alaska

Retrieved on: 
Tuesday, December 21, 2021

New York, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today received a Product Endorsement Approval Notice (“Product Endorsement”) from the State of Alaska.  Specifically, this Endorsement was issued to the Company by Alaska Division of Agriculture (Industrial Hemp Program). 

Key Points: 
  • New York, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (Tauriga or the Company), a New York based diversified Life Sciences Company, today received a Product Endorsement Approval Notice (Product Endorsement) from the State of Alaska.Specifically, this Endorsement was issued to the Company by Alaska Division of Agriculture (Industrial Hemp Program).
  • Please visit our corporate website, for additional information, as well as inquiries, athttp://www.tauriga.com
    Complementary to the Companys retail business, is its ongoing Pharmaceutical Development initiative.
  • This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment).
  • Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.The Patent, filed with the U.S.P.T.O.

Tauriga Sciences Inc. Set to Report Record Quarterly Net Revenue

Retrieved on: 
Friday, December 17, 2021

New York, NY, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it will report record Quarterly Net Revenue, for its current operating Quarter – 3rd Fiscal Quarter 2022 (Period: October 1 – December 31, 2021).  

Key Points: 
  • New York, NY, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (Tauriga or the Company), a New York based diversified Life Sciences Company, today announced that it will report record Quarterly Net Revenue, for its current operating Quarter 3rd Fiscal Quarter 2022 (Period: October 1 December 31, 2021).
  • Continued strength in the Companys highest margin E-Commerce business segment has driven revenue growth.This will be the 2nd consecutive Quarter in which the Company reports record Net Revenue.
  • Please visit our corporate website, for additional information, as well as inquiries, athttp://www.tauriga.com
    Complementary to the Companys retail business, is its ongoing Pharmaceutical Development initiative.
  • Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.The Patent, filed with the U.S.P.T.O.

Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review Board

Retrieved on: 
Friday, December 17, 2021

New York, NY, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it has formally submitted its Clinical Study Protocol (“Protocol”) to the Institutional Review Board (“IRB”).  The Company’s Protocol Title: “The Effect of CBD Gum on Nausea and Vomiting During Pregnancy”.

Key Points: 
  • New York, NY, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (Tauriga or the Company), a New York based diversified Life Sciences Company, today announced that it has formally submitted its Clinical Study Protocol (Protocol) to the Institutional Review Board (IRB).The Companys Protocol Title: The Effect of CBD Gum on Nausea and Vomiting During Pregnancy.
  • Hyperemesis Gravidarum is also known as: Morning Sickness
    On December 16, 2021 the IRB acknowledged receipt of the Companys above-referenced Study Protocol (CIRBI Link: Pro00059685).
  • The IRB will begin Administrative Review of the Protocol Submission, and notify the Company if there are any clarifications required.
  • The Companys proposed Cannabidiol delivery system (via: sublingual absorption / oral mucosa) utilizes its proprietary Cannabidiol infused chewing gum platform.

China Motion Controller Industry Report 2021-2026 Featuring 14 Key Motion Controller Companies in China and 7 International Motion Controller Companies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 14, 2021

The "China Motion Controller Industry Report, 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Motion Controller Industry Report, 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • Motion controllers are divided into general-purpose motion controllers, which include PC-based and PLC-based types, as well as special motion controllers.
  • China Motion Controller Industry Report, 2021-2026 released by the publisher highlights the following:
    Definition, classification, industry chain and technology trends, etc.
  • The operation, revenue structure and development strategies of 14 key motion controller companies in China and 7 international motion controller companies.

China Motion Controller Market Report 2021

Retrieved on: 
Tuesday, December 14, 2021

DUBLIN, Dec. 14, 2021 /PRNewswire/ -- The "China Motion Controller Industry Report, 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 14, 2021 /PRNewswire/ -- The "China Motion Controller Industry Report, 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • In terms of market segments, foreign brand companies target the high-end general-purpose motion controller market in China, while domestic companies are positioned in the medium and low-end market.
  • China Motion Controller Industry Report, 2021-2026 released by the publisher highlights the following:
    Definition, classification, industry chain and technology trends, etc.
  • The operation, revenue structure and development strategies of 14 key motion controller companies in China and 7 international motion controller companies.

EcoFlow, the Industry-leading Portable Power Provider, Rolls Out European Christmas Deals

Retrieved on: 
Monday, December 6, 2021

The DELTA portable power station, originally 1,399 EUR, is now marked down by 11%, selling at 1,249.

Key Points: 
  • The DELTA portable power station, originally 1,399 EUR, is now marked down by 11%, selling at 1,249.
  • The RIVER Max portable power station, previously 649 EUR, now retails at 599 EUR.
  • The RIVER Pro portable power station, with an original price of 749 EUR, is now priced at 699 EUR.
  • Made up of efficient monocrystalline silicon cells and water-resistant material, the solar panel recharges portable power stations while keeping equipment running under a variety of conditions.

Tauriga Sciences Inc. Approved to Renew its Status as a Vendor to the National Association of College Stores

Retrieved on: 
Wednesday, December 1, 2021

via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it has been approved to renew its status as an Affiliate Vendor (“Vendor”) to the National Association of College Stores (“NACS”).  This renewal is valid through Calendar Year 2022.  As a Vendor to the NACS, the Company is part of the most comprehensive group of College Campus Retailers – working to provide the best services and selections to college students across the United States of America.  Additionally, the Company believes that the Collegiate Retail Market (i.e. campus bookstores) represents a potentially lucrative business opportunity during Calendar Year 2022 and beyond.

Key Points: 
  • The National Association of College Stores is the professional trade association of the $10 Billion campus store industry.
  • The NACS represents nearly 4,000 campuses in the U.S. and Canada, and approximately 1,000 companies that supply goods and services to campus stores.
  • Through groundbreaking educational events, productive tradeshows, and award-winning publications, the NACS is the gateway to securing new customers and growing your business in the $10 Billion campus market.
  • Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances.

Tauriga Sciences, Inc. Appoints Matthew A. Shaw as Member of Its Corporate Advisory Board

Retrieved on: 
Wednesday, December 1, 2021

Currently, Matthew A. Shaw serves as Head of Mergers & Acquisitions/Tax (M&A Tax) for the U.S. businesses of Nestl, the worlds largest food and beverage company.

Key Points: 
  • Currently, Matthew A. Shaw serves as Head of Mergers & Acquisitions/Tax (M&A Tax) for the U.S. businesses of Nestl, the worlds largest food and beverage company.
  • In joining Taurigas Corporate Advisory Board, his main focus will be to help the Company in a general strategic advisory role in evaluating opportunities to grow revenue and expand market opportunities.
  • Mr. Matthew A. Shaw is the brother of our Companys CEO, whose valuable business acumen should serve the Company well in his capacity as an advisor.
  • Matthew A. Shaw, J.D., LL.M., draws upon nearly fifteen years of experience providing strategic solutions to multi-billion-dollar corporate tax issues for Fortune 100 companies.

Tauriga Sciences Inc. Generates Record Weekly Net E-Commerce Sales

Retrieved on: 
Monday, November 29, 2021

NEW YORK, NY, Nov. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it has generated record weekly net E-Commerce revenue (“sales”), for the following period: Monday November 22, 2021 through Sunday November 28, 2021. The Company’s net E-Commerce sales, for this one-week period, have exceeded $22,000 for the first time.  The Company is confident about its business prospects for the remainder of Calendar Year 2021 and beyond. 

Key Points: 
  • For the Following Weekly Period: November 22nd-28th, 2021 or Thanksgiving Week 2021
    NEW YORK, NY, Nov. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB:TAUG) (Tauriga or the Company), a New York based diversified Life Sciences Company, today announced that it has generated record weekly net E-Commerce revenue (sales), for the following period: Monday November 22, 2021 through Sunday November 28, 2021.The Companys net E-Commerce sales, for this one-week period, have exceeded $22,000 for the first time.The Company is confident about its business prospects for the remainder of Calendar Year 2021 and beyond.
  • The Company is firmly on track to generate record quarterly revenue (net revenue), for its 3rd Fiscal Quarter 2022.The Company expects that net revenue generated for this quarter, when completed, will be substantially greater than any other previous quarter.
  • Please visit our corporate website, for additional information, as well as inquiries, athttp://www.tauriga.com
    Complementary to the Companys retail business, is its ongoing Pharmaceutical Development initiative.
  • Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.The Patent, filed with the U.S.P.T.O.